ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1891

Proteomic Profile Of Tears: Can It Help To Diagnose Juvenile Arthritis – Associated Uveitis Prior To The Clinical Signs Of Joints Inflammation

Vyacheslav Chasnyk1, Sergei Nekhai2, Alla Hynes3, Tatiana Ammosova4, Yuri Obukhov4, Ekaterina Gaidar5, Anatolyi Kononov5, Margarita Dubko6, Elena Serogodskaia6 and Tatiana Nikitina5, 1Hospital Pediatry, State Pediatric Medical University, Saint-Petersburg, Russia, 2Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, 3Eye Care Physicians and Surgeons, Winchester, VA, 4Howard University, Washington, DC, 5Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia, 6State Pediatric Medical University, Saint-Petersburg, Russia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Diagnostic Tests, Juvenile Arthritis, proteomics and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Approximately 6% of all cases of uveitis arise in children (Nguyen, Foster, 1998). One of the common causes of uveitis is Juvenile Idiopathic Arthritis (JIA). Up to 20% of JIA children have uveitis (Kesen et al., 2008) and often uveitis is the initial clinical manifestation of JIA, the delay of arthritis can be estimated at years which complicates treatment for uveitis and lead to blindness. During the last years the number of proteins identified in tears increased from 200 (Herber et al., 2001) of only 17  (Zhou et al., 2003) different molecular weights (MW) to 491 (de Souza et al., 2006) and  80 chemokines, cytokines, and growth factors (Sack et al., 2005). Objective: to reveal protein markers of JIA-associated uveitis in tears using high-resolution mass-spectrometry.  

Methods: Patients with uveitis were examined by ophthalmologists and rheumatologists and the standard clinical protocol was used to diagnose the disease. Tear samples drawn from 13 JIA-patients and 3 healthy subjects were analyzed. Tears were collected on a filter paper, digested with trypsin and the peptides were purified on Zip tips. The samples were loaded to nano C18 column attached to Shimadzu nano LC coupled in-line to LTQ Orbitrap XL tandem mass spectrometer (Thermo Fischer Scientific, GA, USA). The mass spectra of the peptides were detected with a data-dependent 4-event scan method (a survey FT-MS parent scan followed by sequential data-dependent FT-MS/MS scans on the three most abundant peptide ions from the parent scan). Proteins were identified from the mass spectra results with Proteome Discoverer software for protein database search using the International Protein Index (IPI) Human Protein Database (version 1.79). Quantification was conducted using SIEVE. 

Results: About 3000 proteins were detected in tears. Among those, 236 proteins (MW 7.4 – 466 kDa) were chosen as candidates for early diagnosis of the JIA-associated uveitis. Besides the rheumatoid factors RF-ET12, RF-IP14, RF-IP24, cytokines and T-cell receptor alpha-chain, we identified anti-CD40 single-chain antibody fragment A49, inhibiting protein CD40 which is a member of the TNF-receptor superfamily, lipocalin-1 precursor, associated with immune response and prostaglandin synthesis, clusterin  inhibiting the cytolytic reaction of complement components, anti-TNF-alfa antibody light chain Fab fragment, protein phosphatase, regulatory subunit 15B, which plays a role in cell progression, apoptosis and regulation of membrane receptors and channels, DMBT/8kb.2 protein, which takes part in the interaction of tumor cells and the immune system.

Conclusion:  Our pilot study demonstrates the benefits of high resolution mass- spectrometry for analysis and development of molecular signatures which can be used in future diagnostics. Earlier it was shown that induced anterior uveitis in the eyes of rats can be described in terms of proteins drawn from the anterior chamber (Sobn et al., 2000), which result is close to our terms of description. Our results support the suggestion that it is possible to identify protein markers of JIA-associated uveitis in tears prior to the clinical signs of arthritis.


Disclosure:

V. Chasnyk,
None;

S. Nekhai,
None;

A. Hynes,
None;

T. Ammosova,
None;

Y. Obukhov,
None;

E. Gaidar,
None;

A. Kononov,
None;

M. Dubko,
None;

E. Serogodskaia,
None;

T. Nikitina,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomic-profile-of-tears-can-it-help-to-diagnose-juvenile-arthritis-associated-uveitis-prior-to-the-clinical-signs-of-joints-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology